Overview
- 2 inspections across 2 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-07-18.
At a glance
Inspections
2
Sites
2
Observations
4
Career since
Jul 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pfizer, Inc. | 18 Jul 2018 | Human Drugs | View 483 → |
| Lilly del Caribe, Inc | 21 Jul 2017 | Human Drugs | On file |
Sites inspected
Pfizer, Inc.Groton, United States1 insp.
Lilly del Caribe, IncCarolina, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Hang N Guo1 shared
Chunsheng Cai1 shared
Edmund F Mrak1 shared
Ying Zhang1 shared
Raquel Gonzalez Rivera1 shared
Krishna Ghosh1 shared
Noreen Muniz1 shared
Full investigator report
Get the verbatim findings behind Rapti D Madurawe's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site